Related Experiment Video
Updated: Feb 27, 2026
09:11
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
21.5K
[Zika virus infection: A review].
A Guillier1, E Amazan1, A Aoun1
1Service de dermatologie, CHU La Meynard, 97200 Fort-de-France, Martinique.
Annales De Dermatologie Et De Venereologie
|July 5, 2017
Summary
Zika virus (ZIKV), a mosquito-borne Flavivirus, now presents serious neurological risks, including congenital defects and Guillain-Barre syndrome, alongside new transmission routes. Its global spread prompted a 2016 WHO public health emergency declaration.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Zika virus (ZIKV), a Flavivirus first identified in 1947, is primarily transmitted by Aedes mosquitoes.
- Historically associated with mild, often asymptomatic illness (fever, rash, conjunctivitis), ZIKV has re-emerged.
- Recent outbreaks revealed severe neurological complications and expanded transmission routes.
Purpose of the Study:
- To summarize the re-emergence of Zika virus.
- To highlight novel transmission pathways and severe neurological complications.
- To underscore the global public health threat posed by ZIKV.
Main Methods:
- Review of epidemiological data from recent ZIKV outbreaks.
- Analysis of clinical case reports detailing neurological complications.
- Assessment of ZIKV transmission dynamics.
Main Results:
- ZIKV transmission now includes blood, perinatal, and sexual routes.
- Significant neurological complications identified: congenital defects and Guillain-Barre syndrome.
- Global spread necessitates urgent public health interventions.
Conclusions:
- ZIKV poses a significant threat due to its re-emergence, altered transmission, and severe neurological sequelae.
- The World Health Organization declared ZIKV a public health emergency of international concern in February 2016.
- Continued surveillance and research are critical to manage the global impact of ZIKV.
